TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bionor AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
410
|
314 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
26
|
-12 | |
| EBITDA |
26
|
-11 | |
| Total assets |
110
|
116 | |
| Current assets |
110
|
116 | |
| Current liabilities |
25
|
42 | |
| Equity capital |
86
|
63 | |
| - share capital |
9
|
9 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
78.2%
|
54.3% | |
| Turnover per employee |
410
|
314 | |
| Profit as a percentage of turnover |
6.3%
|
-3.8% | |
| Return on assets (ROA) |
23.6%
|
-10.3% | |
| Current ratio |
440.0%
|
276.2% | |
| Return on equity (ROE) |
30.2%
|
-19.0% | |
| Change turnover |
95
|
-15 | |
| Change turnover % |
4%
|
30%
|
-5% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.